Simon J. Bowman

Milton Keynes, ENG MK65LD, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 134 publications

Sjogren's Disease-Aspects of Clinical Disease Beyond Dry Eyes/Mouth.

Sjogren's Disease-Aspects of Clinical Disease Beyond Dry Eyes/Mouth.

Journal: Journal of clinical medicine

Published: January 06, 2026

Clinical features and pathogenesis of Sjogrens disease related peripheral neuropathy and their relevance to clinical trials.

Clinical features and pathogenesis of Sjogrens disease related peripheral neuropathy and their relevance to clinical trials.

Journal: Communications medicine

Published: December 15, 2025

Activity and Damage Indices for Sjögren's Disease.

Activity and Damage Indices for Sjögren's Disease.

Journal: Journal of clinical medicine

Published: December 10, 2025

Emerging treatments for Sjögren's disease: promising drugs on the horizon.

Emerging treatments for Sjögren's disease: promising drugs on the horizon.

Journal: RMD open

Published: November 26, 2025

Impact of smoking status on Sjögren's disease diagnosis and phenotype: results from a cohort study with matched population controls.

Impact of smoking status on Sjögren's disease diagnosis and phenotype: results from a cohort study with matched population controls.

Journal: Rheumatology (Oxford, England)

Published: November 17, 2025

Sjögren Disease: Does an Accurate Diagnosis Matter?

Sjögren Disease: Does an Accurate Diagnosis Matter?

Journal: The Journal of rheumatology

Published: November 01, 2025

Evolution and prospects for the definition of clinically useful endpoints in Sjögren disease.

Evolution and prospects for the definition of clinically useful endpoints in Sjögren disease.

Journal: Current opinion in immunology

Published: October 24, 2025

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease.

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease.

Journal: Annals of the rheumatic diseases

Published: September 24, 2025

OMERACT- determining a core domain set for Sjögren's disease: International focus group series.

OMERACT- determining a core domain set for Sjögren's disease: International focus group series.

Journal: Seminars in arthritis and rheumatism

Published: September 20, 2025

Impact of socioeconomic deprivation on risk and disease activity of Sjögren's disease.

Impact of socioeconomic deprivation on risk and disease activity of Sjögren's disease.

Journal: RMD open

Published: September 14, 2025

Patients' perspectives of living with Sjögren disease: A systematic review of qualitative studies from the OMERACT Sjögren disease working group.

Patients' perspectives of living with Sjögren disease: A systematic review of qualitative studies from the OMERACT Sjögren disease working group.

Journal: Seminars in arthritis and rheumatism

Published: August 08, 2025

Hormonal risk factors and androgen and glucocorticoid dysregulation in Sjogren's disease and non-Sjogren's sicca.

Hormonal risk factors and androgen and glucocorticoid dysregulation in Sjogren's disease and non-Sjogren's sicca.

Journal: Rheumatology (Oxford, England)

Published: May 16, 2025

Showing 1-12 of 134

Last Updated: 09/26/2026